MS diet decreases CCR2 expression in F1 T cells. by Colin Delaney (380939)

Subgroup analysis of comparing HbA1c% (A), HOMA-IR (B) and plasma glucose (mmol/L) (C) between bariatric surgery and conventional medical groups by different surgery types. by Guoli Yan (4591687)

Knockdown of ErbB2 decreases phosphorylation of Akt and CNC migration. by Ketan Mathavan (4634704)

ß2AR stimulation decreases tumor cell growth in vitro by J. Preston Campbell (150756)

dMi-2 decreases the stability and extent of cohesin chromosome binding. by Barbara Fasulo (144611)

“…<p>(A) FRAP recovery curves for EGFP-Smc1 in wild-type salivary gland nuclei, and salivary gland nuclei in which <i>da-GAL4</i> drives the expression of two <i>UAS-dMi-2⁺</i> transgenes (<i>EGFP-Smc1 da-GAL4/UAS-dMi-2⁺ 3-3; UAS-dMi-2⁺ 15-1/+</i>) at 25°C. …”

Inhibition of inflammatory signalling pathways decreases HSV-2 viral shedding. by Victor H. Ferreira (719813)

PSD-95 decreased ASIC2a acid-evoked current. by Anne Marie S. Harding (546425)

Acetaminophen decreases mitochondrial respiration of intact HepG2 cells. by Sarah Piel (3143667)

Inhibition of ABCG2 decreases SP cells, but not sphere-forming ability. by Noriko Kawai (6694010)

<i>upd2</i> down-regulation decreases sleep intensity. by Deniz Ertekin (9199661)

<i>DSPP</i> silencing decreased OSC2 migration and invasion. by Rajeshree Joshi (237499)

“…<p>(A, B) Modified Boyden-Chamber experiment shows that <i>DSPP</i>-silencing in (L2) decreased invasion (A) and migration (B) of OSC2 cells by ∼25%, respectively, compared to shC control and parental OSC2 cells (for each comparison using Dunn methods of multiple comparisons).…”

COMMD7 silencing decreased HepG2 cell proliferation. by Lu Zheng (132726)

FHL2 silencing decreases bone tumor cell migration and invasion. by Julia Brun (286504)

RhoC overexpression in MCF10A cells results in a decrease in WISP3 mRNA level by Celina G Kleer (2440)

“…<p><b>Copyright information:</b></p><p>Taken from "WISP3 and RhoC guanosine triphosphatase cooperate in the development of inflammatory breast cancer"</p><p>Breast Cancer Research 2003;6(2):R110-R115.…”

Mice deficient for <i>Asxl2</i> have decreased BMD. by Charles R. Farber (108079)

“…<p>Male mice deficient in <i>Asxl2</i> (−/−) display significant decreases relative to wild-type controls (+/+) in (A) TBMD, (B) SBMD and (C) FBMD residuals after adjusted for age and body weight. …”

TIPE2 deficiency increases NO production but decreases urea production in macropahges. by Yunwei Lou (560831)

Ulk2 morphants have a decreased extension/retraction ratio. by Stacey Lee (647217)

Ang 1–7 decreased Ang II-stimulated ER stress. by Dharmani Murugan (841819)

The PittII Msf-KO strain has decreased survival in macrophages. by Jennifer M. Kress-Bennett (3179382)

R1R2 decreases collagen content in the ligated vessel. by Ting-Hein Lee (225627)